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 Implication for health policy/practice/research/medical education:
Autoimmune hepatitis is a quite serious disease, and will get worse if not treated properly. Early and accurate diagnosis is extreme-
ly important for these patients in order to receive proper treatment. The autoimmune hepatitis should be considered in patients 
with elevated liver enzyme and dermatological manifestation.
Background: Autoimmune hepatitis (AIH) is a form of chronic hepatitis with unclear 
causative factors and is characterized by immunological and auto-immunological man-
ifestations. Several extrahepatic manifestations, such as other autoimmune disorders, 
are associated with AIH. AIH with dermatological conditions as the initial manifestation 
is rare. We report the case of AIH in which erythema nodosum (EN) was the first mani-
festation.
Case Presentation: An 8-year-old girl with several persistent dermatological lesions was 
referred to our hospital several months ago. Her skin had nodular, painful, dry, and er-
ythematous lesions, predominantly on the extensor areas of both the legs, with some 
erythematous patches on her face. Physical examination revealed that she had hepa-
tosplenomegaly as well. Skin biopsy indicated EN. The results of the laboratory tests 
showed increased levels of several liver enzymes. The patient’s International Autoim-
mune Hepatitis Group (IAIHG) score was a definite indicator of AIH. The results of liver 
biopsy indicated AIH. Other causes of EN and abnormal liver function were ruled out. 
The only obvious cause of skin lesions was chronic inflammation due to an autoimmune 
response. The patient was treated for AIH, and her skin lesions along with other signs 
and symptoms resolved. 
Conclusions: AIH can present with protean clinical manifestations, and is thus associated 
with the risk of delayed diagnosis. Dermatological manifestations, including EN, could 
indicate a serious disease, and further investigation might be required. AIH should be 
considered as the possible diagnosis in such cases.
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1. Background
Autoimmune  hepatitis  (AIH),  previously  known  as 
chronic active hepatitis or lupoid hepatitis, is a form of 
chronic hepatitis of uncertain or unknown etiology char-
acterized by immunological and autoimmunological 
manifestations and is usually accompanied by the pres-
ence of circulating autoantibodies and high serum glob-
ulin concentrations (1). AIH occurs in adults and children 
of all ages, mainly affecting females, and it occasionally 
has a fluctuating course, with periods of increased or 
diminished activity. AIH responds dramatically to im-
munosuppressive  therapy,  but  when  left  untreated,  it 
progressively and rapidly develops into cirrhosis and 
liver failure (2, 3). AIH is responsible for approximately 
2–5% of chronic liver diseases in children. Its incidence in 
Europe is 0.69 per 100,000 of the adult population. The 
prevalence of pediatric AIH has not been documented (2-
5). AIH often follows a more acute and aggressive course 
in children and young adults than in middle-aged and 
elderly patients (6).
The recent classification of AIH is based on the type of 
serum autoantibodies that are produced, although there 
is little evidence supporting the role of these antibod-
ies in the pathogenesis of this disorder. Two main types 
of AIH have been delineated. Type 1 (Classic) AIH occurs 
mostly in females of all age groups; it is characterized by 
the presence of anti-nuclear antibody (ANA) and/or anti-
smooth muscle antibody (SMA). Type 2 AIH commonly 
occurs in girls and young women and is characterized by 
the presence of anti-liver kidney microsomal antibody 
type 1 (anti-LKM-1) (1, 3, 6). The cause of AIH is not clearly 
known, but overactivity and dysregulation of immune 
cells (especially CD8 lymphocytes) is thought to be the 
main cause of this disease (1). The signs and symptoms of 
AIH vary and are similar to those of other autoimmune 
disorders;  AIH  patients  may  present  with  nonspecific 
symptoms,  such  as  extrahepatic  manifestations.  One 
of the organs involved in AIH is skin. Pruritus, urticaria 
pigmentosa, vitiligo, erythema annulare centrifugum, 
and cutaneous polyarteritis nodosa are some of the skin 
manifestations of AIH (7-10). Erythema nodosum (EN) is a 
skin lesion associated with some autoimmune diseases 
such as inflammatory bowel syndrome and Behçet syn-
drome, and some non-autoimmune disorders such as 
tuberculosis, bacterial or deep fungal infection, sarcoid-
osis, and cancer (11-13). EN seems to occur less frequently 
in children than in adults (14). Although AIH is an auto-
immune disease and EN is not unusual in autoimmune 
disorder, there are few reports of an association between 
EN and AIH (15). We discuss the case of pediatric AIH in 
which EN was the initial presentation.
2. Case Presentation 
An 8-year-old girl was under observation at our derma-
tology outpatient clinic because of several skin lesions 
that had persisted for 5–6 months. Initially, the patient 
was diagnosed as having eczema and topical treatment 
was started. Over a 2-month period, the patient showed 
no  improvement  and  showed  the  additional  clinical 
presentations of epigastric abdominal discomfort, weak-
ness, asthenia, occasional nausea, and vomiting and was 
referred to the pediatric ward. The skin lesions were pres-
ent on both the legs and were tender, erythematous, nod-
ular, with a predominantly nodular shape and without 
any discharge (Figure 1). Skin biopsy of the erythematous 
nodule revealed full thickness subcutaneous fat infiltra-
tion  with  lymphocytic  white  blood  cell  (panniculitis) 
without any evidence of vasculitis. The mentioned find-
ings were consistent with a diagnosis of erythema nodo-
sum (16). She did not have a history of musculoskeletal 
complaint, pharyngitis, blood transfusion, or any medi-
cations, all of which was consistent with her condition. 
She had no family history of chronic liver disease or any 
autoimmune  disorders  either.  Physical  examination 
revealed mild hepatosplenomegaly, without any other 
peripheral stigmata of liver disease. Her vital signs were 
stable.
The results of the laboratory tests were as follows: WBC 
count, 4,500 × 10(6) / lit (neutrophils: 39%, lymphocytes: 
55%,  and  others:  6%);  hypochromic  microcytic  anemia 
(hemoglobin:  10.3  g/dL,  MCV:  71);  platelets,  174,000/µL; 
erythrocyte sedimentation rate, 24; creatinine level, 0.9 
mg/dL; total bilirubin, 1.6 mg/dL and direct bilirubin, 0.4 
mg/dL;  serum  aspartate  aminotransfarase  (AST)  level, 
348  IU/L  (normal  level,  up  to  40  IU/L);  alanine  amino-
transferase (ALT) level, 555 IU/L (normal level, up to 40 
IU/L), alkaline phosphatase (ALP) level, 395 IU/L (normal 
level, up to 1800 IU/L in pediatric patients); and lactate 
dehydrogenase (LDH) level, 612 IU/L (normal level, up to 
450 IU/L). The results of hemostatic screening tests (for 
the prothrombin time and international normalized ra-
tio) were normal. Serum protein electrophoresis showed 
total protein level of 6.9 g/dL (normal range, 6.0–8.4 g/
dL), albumin level of 3.6 g/dL (normal range, 3.5–5.0 g/dL), 
and globulin level of 2.97 g/dL (normal range, 2.3–3.5 g/
dL). Her blood samples were not positive for HBs antigen, 
Figure 1. The Skin Lesions Were Present on Both the Legs and Were Ten-
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anti-HBc antibody, anti-hepatitis A virus immunoglobu-
lin M, and anti-hepatitis C virus antibody. The results of 
the serological tests were negative for cytomegalovirus, 
Epstein–Barr virus, Toxoplasma, and Brucella. The strep-
tococcal  anti-streptolysin  O  titer  was  not  remarkable. 
Smears of gastric secretion and the microbial culture 
were negative for the tuberculin bacilli as were the re-
sults of the Koch bacillus (BK) and purified protein de-
rivative (PPD) skin tests. The results of the serological 
tests for anti-staphylococcal and anti-streptococcal an-
tibodies were also negative. The serum and urine levels 
of ferritin, ceruloplasmin, α1-antitrypsin, and γ-glutamyl 
transpeptidase were normal. Urine analysis did not show 
any abnormalities, and there were no clinical and labora-
tory findings suggesting diabetes mellitus, thyroiditis, 
Graves’ disease, or proliferative glomerulonephritis.
Abdominal  ultrasonography  showed  increased  liver 
size, with a coarse echotexture, but it did not show any 
evidence of portal hypertension and ascites. The results 
of  chest  computed  tomography  were  unremarkable. 
Ophthalmological examination did not show any Kay-
ser–Fleischer ring. An assessment of the immunoserolog-
ical markers showed that anti-SMA was present at a titer 
of 1: 160, but serum ANA, anti-mitochondrial antibodies 
(AMA), and anti-LKM antibodies were not. The results of 
human leukocyte antigen typing were positive for DR3 
and DR4. Other possible causes of EN were ruled out (12). 
Liver  biopsy  revealed  lymphocytic  infiltration  with  a 
mild degree of fibrosis, rosette formation, and other his-
topathological findings (interface hepatitis), indicating 
chronic autoimmune hepatitis.
The only obvious cause of skin lesions was chronic in-
flammation  due  to  an  autoimmune  response.  The  pa-
tient was diagnosed as having type-1 AIH associated with 
EN, and a course of prednisolone with azathioprine was 
started in the second week. The patient scores for the 
diagnosis of AIH were calculated according to the Inter-
national Autoimmune Hepatitis Group (IAIHG) revised 
scoring system (17). The pre-treatment IAIHG score of the 
patient was 19, which is a definite indicator of AIH. Dur-
ing the first follow-up (after 4 weeks of therapy), abdomi-
nal discomfort, weakness, asthenia, and fatigue were en-
tirely resolved, and the skin nodules were significantly 
improved. Serum aminotransferase levels were near nor-
mal. The changes in the levels of serum aminotransfer-
ases during treatment have been shown in Figure 2. The 
skin lesions completely remitted after 3 months of treat-
ment. We started the treatment with the prednisolone 
(2 mg/ kg/ d) and azathioprine (2 mg/kg/ d). The immu-
nosuppressive therapy was tapered with the administra-
tion of prednisone (0.5 mg/kg/day) and azathioprine (1 
mg/kg/d) as a maintenance regimen when we found that 
the levels of serum aminotransferases remained normal 
the first follow up. Our patient is currently doing well, as 
indicated by the normal results of the laboratory tests 
and after the 6-month follow-up post-treatment.
3. Discussion
EN is a type of panniculitis (inflammation of subcuta-
neous adipose tissue in the skin) that is clinically char-
acterized by acute-onset skin eruptions such as tender 
erythematous  nodules  located  mostly  over  the  exten-
sor surfaces of the legs (especially shins) (16). EN occurs 
in  about  1–5  individuals  per  100,000  persons.  Various 
wide-spectrum  general  and  local  conditions  can  trig-
ger EN. Streptococcal infections are the most common 
identifiable  cause  of  EN,  especially  in  children.  Other 
bacterial and viral infections, drugs, sarcoidosis, inflam-
matory bowel disease, and autoimmune disorders are 
the other common causes of EN (12, 14). Sometimes, EN 
is the sign of an autoimmune disease such as ankylos-
ing spondylitis, antiphospholipid antibody syndrome, 
Behçet’s  syndrome,  Reiter’s  syndrome,  rheumatoid  ar-
thritis, Sjögren’s syndrome, systemic lupus erythemato-
sus, Takayasu’s arteritis, and Wegener’s granulomatosis, 
which can be potentially relieved with immunosuppres-
sive  and  supportive  therapy  (16,  18).  EN  is  considered 
to be a reactive process that is caused by an inordinate 
response of the immune system to various trigger fac-
tors. The histopathological mechanism that explains the 
involvement of the immune system in EN is deposition 
of immune complexes and infiltration of neutrophils in 
the connective tissue septa of subcutaneous fat (16).
AIH, like other autoimmune diseases, is characterized 
by necroinflammation of the liver due to lymphocytic 
infiltrations, presence of circulating non-organ-specific 
autoantibodies, and hypergammaglobulinemia with an 
unknown cause. The causative factor of AIH is not clearly 
known; however, an extrinsic factor is believed to activate 
a T-cell-mediated response against hepatocyte antigen in 
patients with genetic susceptibility (1, 2). We report the 
case of an 8-year-old girl with AIH who presented with EN 
as the initial manifestation. AIH, like the other autoim-
mune disorders, involves various organs, especially, the 
connective  tissues.  However,  skin  involvement  as  the 
initial manifestation of AIH is rare and improbable (15). 
Irregularities in the responses from the humoral and 
cellular immune systems in the case of both AIH and EN 
may explain the association between them. Our patient 
responded to treatment adequately and her cutaneous 
lesions  resolved,  which  confirms  the  association  be-
tween AIH and EN. AIH associated with EN is a rare clini-
cal condition, where EN is the initial clinical manifesta-
Figure 2. Changes in the Levels of Serum Aminotransferases During the 
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tion. Sometimes, the initial clue to a hepatic disorder is 
a skin manifestation (10). It is necessary for physicians 
to be well-versed with cutaneous presentations in liver 
disease, in order to diagnose the underlying disorder as 
soon as possible.
4. Conclusion
AIH can present with many misleading clinical mani-
festations, increasing the risk of delayed diagnosis. This 
case  showed  that  in  the  case  of  obscure  symptoms,  a 
thorough investigation is required for accurate diagno-
sis of AIH. In the case of a child with elevated levels of 
liver enzymes, AIH should be considered as a possible 
diagnosis when the results of other laboratory tests are 
inconclusive. Dermatological disorders can be a presen-
tation of serious diseases such as AIH, and further inves-
tigation may be required.
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